| 注册
首页|期刊导航|重庆医学|进展期胃癌新辅助化疗疗效的Meta分析

进展期胃癌新辅助化疗疗效的Meta分析

肖凤 刘彬 高红英 伍吉云 朱清仙

重庆医学2012,Vol.41Issue(25):2591-2594,4.
重庆医学2012,Vol.41Issue(25):2591-2594,4.DOI:10.3969/j.issn.1671-8348.2012.25.009

进展期胃癌新辅助化疗疗效的Meta分析

A Meta analysis on curative effects of neoadjuvant chemotherapy for treating advanced gastric cancer

肖凤 1刘彬 1高红英 2伍吉云 2朱清仙1

作者信息

  • 1. 南昌大学医学院病理学系,江西南昌,330006
  • 2. 井冈山大学医学院基础医学部,江西吉安,343000
  • 折叠

摘要

Abstract

Objective To study the value of neoadjuvant chemotherapy( NAC) for treating advanced gastric cancer by performing a Meta-analysis of the published studies. Methods Searching the data bases Cochrane libraries, PubMed,Kmbase,Chinese Bio-medical Literature Database(CBM) ,Chinese Scientific Journal Full-Text Database(CSJD) and Chinese Journal Full-Text Database (CJFD),aided with manual retrieval and other retrievals, the Meta analysis was performed by using RevMan 5. 0. 2 software. Results Eighteen randomized controlled trials involved 2685 patients were included. Significantly statistical differences were found in the overall survival rate,5-year survival rate and the resection rate between the neoadjuvant chemotherapy group and the surgery group odds ratio(OR):1. 40,95% confidence interval(CI):1. 17 - 1. 68 for the overall survival rate;OR:1. 96,95% CI:1. 44 - 2. 67 for the 5-year survival rate;OR : 1. 60,95% CI: 1. 29 - 1. 97 for the resection rate,and no statistical differences were found in periop-erative mortality(OR: 1. 06,95% CI:0. 60 - 1. 82,P>0. 05). Conclusion NAC can improve the tumor resection rate and the survival rate in the patients with advanced gastric cancer without increasing the operative risk.

关键词

胃肿瘤/化学疗法,辅助/Meta分析/生存率

Key words

stomach neoplasms/chemotherapy,adjuvant/Meta-analysis/survival rate

引用本文复制引用

肖凤,刘彬,高红英,伍吉云,朱清仙..进展期胃癌新辅助化疗疗效的Meta分析[J].重庆医学,2012,41(25):2591-2594,4.

重庆医学

OA北大核心CSCDCSTPCD

1671-8348

访问量0
|
下载量0
段落导航相关论文